RESUMEN
BACKGROUND: Imaging is a key diagnostic modality for suspected invasive pulmonary or sinus fungal disease and may help to direct testing and treatment. Fungal diagnostic guidelines have been developed and emphasize the role of imaging in this setting. We review and summarize evidence regarding imaging for fungal pulmonary and sinus disease (in particular invasive aspergillosis, mucormycosis and pneumocystosis) in immunocompromised patients. OBJECTIVES: We reviewed data on imaging modalities and findings used for diagnosis of invasive fungal pulmonary and sinus disease. SOURCES: References for this review were identified by searches of PubMed, Google Scholar, Embase and Web of Science through 1 April 1 2023. CONTENT: Computed tomography imaging is the method of choice for the evaluation of suspected lung or sinus fungal disease. Although no computed tomography radiologic pattern is pathognomonic of pulmonary invasive fungal disease (IFD) the halo sign firstly suggests an angio-invasive pulmonary aspergillosis while the Reversed Halo Sign is more suggestive of pulmonary mucormycosis in an appropriate clinical setting. The air crescent sign is uncommon, occurring in the later stages of invasive aspergillosis in neutropenic patients. In contrast, new cavitary lesions should suggest IFD in moderately immunocompromised patients. Regarding sinus site, bony erosion, peri-antral fat or septal ulceration are reasonably predictive of IFD. IMPLICATIONS: Imaging assessment of the lung and sinuses is an important component of the diagnostic work-up and management of IFD in immunocompromised patients. However, radiological features signs have sensitivity and specificity that often vary according to underlying disease states. Periodic review of imaging studies and diagnostic guidelines characterizing imaging findings may help clinicians to consider fungal infections in clinical care thereby leading to an earlier confirmation and treatment of IFD.
Asunto(s)
Aspergilosis , Infecciones Fúngicas Invasoras , Aspergilosis Pulmonar Invasiva , Mucormicosis , Humanos , Mucormicosis/diagnóstico por imagen , Mucormicosis/patología , Pulmón/diagnóstico por imagen , Pulmón/patología , Aspergilosis/diagnóstico , Aspergilosis Pulmonar Invasiva/diagnóstico por imagen , Infecciones Fúngicas Invasoras/diagnóstico por imagen , Infecciones Fúngicas Invasoras/patología , Huésped InmunocomprometidoRESUMEN
Since COVID-19 spread worldwide, invasive fungal rhinosinusitis (IFRS) has emerged in immunocompromised patients as a new clinical challenge. In this study, clinical specimens of 89 COVID-19 patients who presented clinical and radiological evidence suggestive of IFRS were examined by direct microscopy, histopathology, and culture, and the isolated colonies were identified through DNA sequence analysis. Fungal elements were microscopically observed in 84.27% of the patients. Males (53.9%) and patients over 40 (95.5%) were more commonly affected than others. Headache (94.4%) and retro-orbital pain (87.6%) were the most common symptoms, followed by ptosis/proptosis/eyelid swelling (52.8%), and 74 patients underwent surgery and debridement. The most common predisposing factors were steroid therapy (n = 83, 93.3%), diabetes mellitus (n = 63, 70.8%), and hypertension (n = 42, 47.2%). The culture was positive for 60.67% of the confirmed cases, and Mucorales were the most prevalent (48.14%) causative fungal agents. Different species of Aspergillus (29.63%) and Fusarium (3.7%) and a mix of two filamentous fungi (16.67%) were other causative agents. For 21 patients, no growth was seen in culture despite a positive result on microscopic examinations. In PCR-sequencing of 53 isolates, divergent fungal taxons, including 8 genera and 17 species, were identified as followed: Rhizopus oryzae (n = 22), Aspergillus flavus (n = 10), A. fumigatus (n = 4), A. niger (n = 3), R. microsporus (n = 2), Mucor circinelloides, Lichtheimia ramosa, Apophysomyces variabilis, A. tubingensis, A. alliaceus, A. nidulans, A. calidoustus, Fusarium fujikuroi/proliferatum, F. oxysporum, F. solani, Lomentospora prolificans, and Candida albicans (each n = 1). In conclusion, a diverse set of species involved in COVID-19-associated IFRS was observed in this study. Our data encourage specialist physicians to consider the possibility of involving various species in IFRS in immunocompromised and COVID-19 patients. In light of utilizing molecular identification approaches, the current knowledge of microbial epidemiology of invasive fungal infections, especially IFRS, may change dramatically.
Invasive fungal rhinosinusitis (IFRS) may infect people with diabetes, cancer, or COVID-19. In this study, various types of fungi were identified from COVID-19-associated-IFRS, encouraging physicians to consider specific treatments.
Asunto(s)
COVID-19 , Hongos , Infecciones Fúngicas Invasoras , Sinusitis , COVID-19/complicaciones , COVID-19/microbiología , Sinusitis/complicaciones , Sinusitis/epidemiología , Sinusitis/microbiología , Hongos/clasificación , Hongos/genética , Hongos/aislamiento & purificación , Infecciones Fúngicas Invasoras/epidemiología , Infecciones Fúngicas Invasoras/microbiología , Infecciones Fúngicas Invasoras/patología , Infecciones Fúngicas Invasoras/cirugía , Factores de Riesgo , Reacción en Cadena de la Polimerasa , ADN de Hongos/genética , Irán/epidemiología , Humanos , Masculino , Femenino , BiodiversidadRESUMEN
INTRODUCTION: Granulomatous infections are common in patients with chronic lung disease. We aim to study the incidence and clinicopathological features of granulomatous infections in a cohort of patients undergoing lung transplantation for end-stage chronic lung disease. METHODS: Pathology reports of 50 explanted native lungs of patients who underwent lung transplantation since 2015 at our institution were reviewed. Four cases with granulomatous lesions were identified. Correlation was made with clinical findings in the 4 cases. RESULTS: The granulomatous infections include non-necrotizing cryptococcal pneumonitis (case 1), necrotizing pneumonia due to Scedosporium sp. and Mycobacterium avium Complex (MAC) (Cases 2 and 3), and invasive Aspergillus pneumonia (Case 4). One patient received pre-transplant fungal prophylaxis (Case 4). Post-transplant infectious complications included invasive (Cases 2 and 4) and non-invasive (Case 1) fungal infections and bacterial pneumonia (Cases 1 and 2). Two patients (Cases 3 and 4) developed acute cellular rejection (ACR) in the first 30 days. The third patient (Case 1) was identified with ACR in the 9 months post-transplant and chronic lung allograft dysfunction at 29 months. In terms of mortality, 1 patient (Case 1) died at 30 months post-transplant from pseudomonal sepsis and chronic graft failure. Two patients with invasive fungal infections (Cases 2 and 4) are on secondary prophylaxis and doing well. One patient (Case 3) remains infection-free and on MAC prophylaxis. CONCLUSIONS: In our case series, patients with chronic lung diseases with superimposed granulomatous infestations frequently experienced post-transplant complications. These include invasive infections and repeat ACRs that predispose patients to chronic graft dysfunction. Pre- and post-transplant antifungal prophylaxis reduces fungal load and complication risk post-transplant.
Asunto(s)
Infecciones Fúngicas Invasoras , Trasplante de Pulmón/efectos adversos , Infecciones por Mycobacterium no Tuberculosas , Anciano , Aspergillus fumigatus/aislamiento & purificación , Femenino , Granuloma , Humanos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/etiología , Infecciones Fúngicas Invasoras/patología , Enfermedades Pulmonares/complicaciones , Enfermedades Pulmonares/patología , Masculino , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/etiología , Infecciones por Mycobacterium no Tuberculosas/patología , Micobacterias no Tuberculosas/aislamiento & purificación , Complicaciones Posoperatorias , Estudios Retrospectivos , Scedosporium/aislamiento & purificación , Resultado del TratamientoRESUMEN
BACKGROUND: The incidence and risk factors for invasive mold infections (IMI) in acute myeloid leukemia (AML) patients carrying FLT3 mutations have not been addressed. PATIENTS AND METHODS: This retrospective cohort included FLT3-mutated AML patients (2008-2018). Primary outcome was IMI incidence within 6 months after first induction or salvage therapy. RESULTS: We included 108 patients receiving fluconazole or micafungin prophylaxis. IMI incidence after induction and salvage therapy was 4.8% and 14.8%, respectively, and did not differ between patients receiving 3+7 regimen or 3+7 plus midostaurin (4.3% vs 4.5%). In a bivariate analysis, age (odds ratio, 1.11; P = .027) and FLT3 ITD mutation (odds ratio, 0.05; P = .023) were independently associated with IMI after induction chemotherapy. Gilteritinib was more frequently prescribed in patients with relapsed/refractory disease who developed IMI (50% vs 27.3%, P = .563). CONCLUSION: FLT3 ITD mutation may be a preventive factor for IMI. Neither midostaurin nor salvage gilteritinib significantly increased the risk of IMI in this population.
Asunto(s)
Infecciones Fúngicas Invasoras/etiología , Leucemia Mieloide Aguda/complicaciones , Tirosina Quinasa 3 Similar a fms/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Infecciones Fúngicas Invasoras/patología , Masculino , Persona de Mediana Edad , Mutación , Estudios Retrospectivos , Adulto JovenRESUMEN
BACKGROUND: Diagnosis of invasive fungal infections from formalin-fixed paraffin-embedded (FFPE) tissues by PCR amplification is a developing technology. One of the difficulties of establishing a validated protocol for this testing is that the gold standard, culture, is much less sensitive than the test being validated. OBJECTIVES: To validate FFPE PCR as a refence laboratory identification methodology in the absence of abundant gold standard specimens. METHODS: In this validation, PCR from FFPE tissue was compared to other diagnostic methods for genus/species identification. Four different groups of correlative data from FFPE tissues were used to validate this procedure. Thirteen specimens had culture or serology results and FFPE PCR results, 49 specimens had both immunohistochemistry (IHC) identification and FFPE PCR results, 118 specimens had histological evidence of fungal elements, 64 of which also had FFPE PCR results, and 36 fungal mock tissues or fungal negative tissues were used. RESULTS: The sensitivity determined from the tissues with positive fungal histopathology was 54%. The specificity of the cases for which there were both culture and FFPE PCR results was 100%. For the correlation with IHC, the specificity was 98%. For the mock tissues and fungal negative tissues, the calculated analytical sensitivity was 94%, specificity was 95%, and accuracy was 94%. CONCLUSIONS: By uniquely combining various data sources, this study provides a comprehensive framework for how validation can be achieved in the absence of a gold standard and outlines the excellent performance of PCR from FFPE tissue, despite relatively the low sensitivity when compared to histopathology.
Asunto(s)
Infecciones Fúngicas Invasoras/diagnóstico , Técnicas de Diagnóstico Molecular/métodos , Adhesión en Parafina , Reacción en Cadena de la Polimerasa/métodos , ADN de Hongos/genética , Formaldehído , Hongos/genética , Hongos/aislamiento & purificación , Humanos , Inmunohistoquímica , Infecciones Fúngicas Invasoras/patología , Laboratorios , Sensibilidad y EspecificidadRESUMEN
The development of disseminated cryptococcosis has historically occurred in patients living with advanced human immunodeficiency virus or other immunosuppressive conditions affecting T-cell function. Recently, patients with anti-cytokine neutralising autoantibodies have been recognised to be at risk for disseminated infections by opportunistic intracellular pathogens, including Cryptococcus species. Herein, we present a previously healthy 26-year-old man who was evaluated with disseminated cryptococcosis involving the bone, lung, mediastinum and brain. The patient's serum cryptococcal antigen titres were >1:1,100,000, and evaluation for an underlying immunodeficiency revealed high titres for anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies. We also review the literature of all published cases of disseminated cryptococcosis associated with the presence of anti-GM-CSF autoantibodies. Clinicians should have a heightened awareness of anti-cytokine autoantibodies in patients without a known immunodeficiency and development disseminated infections by opportunistic intracellular pathogens.
Asunto(s)
Autoanticuerpos/inmunología , Criptococosis , Cryptococcus/inmunología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Infecciones Oportunistas Relacionadas con el SIDA/complicaciones , Adulto , Autoanticuerpos/sangre , Huesos/microbiología , Huesos/patología , Criptococosis/inmunología , Criptococosis/patología , Citocinas/inmunología , Humanos , Terapia de Inmunosupresión , Infecciones Fúngicas Invasoras/inmunología , Infecciones Fúngicas Invasoras/patología , Pulmón/microbiología , Pulmón/patología , Masculino , Meningitis Criptocócica/diagnóstico , Meningitis Criptocócica/patologíaRESUMEN
Invasive sino-orbital aspergillosis is a rare cause of orbital apex syndrome (OAS) in immunocompetent patients and often misdiagnosed as tumour because of its aggressive nature and invasive patterns. We report a 23-year-old immunocompetent man presenting with painful progressive loss of vision, ophthalmoplegia and proptosis of the right eye suggestive of OAS. MRI with gadolinium contrast showed an enhancing heterogeneous mass filling the paranasal sinuses, extraconal space and extending up to the right orbital apex. A functional endoscopic biopsy reported as invasive sino-orbital aspergillosis. He was started on intravenous voriconazole and maximal surgical debridement was done. He gradually regained his vision to 20/30 in the right eye. A review of literature reported several such cases which were managed medically or surgically but with poor visual recovery. This case highlights the need for awareness among clinicians for early diagnosis and treatment to prevent vision loss and better survival.
Asunto(s)
Aspergilosis/diagnóstico , Errores Diagnósticos , Infecciones Fúngicas Invasoras/diagnóstico , Enfermedades Orbitales/diagnóstico , Neoplasias Orbitales/diagnóstico , Sinusitis/diagnóstico , Aspergilosis/patología , Aspergilosis/fisiopatología , Exoftalmia/fisiopatología , Humanos , Inmunocompetencia , Infecciones Fúngicas Invasoras/patología , Infecciones Fúngicas Invasoras/fisiopatología , Imagen por Resonancia Magnética , Masculino , Oftalmoplejía/fisiopatología , Enfermedades Orbitales/patología , Enfermedades Orbitales/fisiopatología , Sinusitis/patología , Sinusitis/fisiopatología , Trastornos de la Visión/fisiopatología , Adulto JovenRESUMEN
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in children with cancer. Studies on the clinical characteristics of IFI in children with solid tumors are limited. This Dutch retrospective cohort study reviewed the medical records of 61 children with solid tumors to analyze the clinical characteristics during their full treatment period. Seven IFI episodes were reported in 6/61 patients (10%), all diagnosed with intermediate-risk or high-risk Wilms tumor or neuroblastoma. Larger studies are necessary to reveal the determinants of IFI in this group of patients and the value of fungal prophylaxis.
Asunto(s)
Infecciones Fúngicas Invasoras/complicaciones , Neoplasias/complicaciones , Antifúngicos/uso terapéutico , Antineoplásicos/uso terapéutico , Niño , Preescolar , Femenino , Humanos , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/patología , Masculino , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Neuroblastoma/complicaciones , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/patología , Estudios Retrospectivos , Tumor de Wilms/complicaciones , Tumor de Wilms/tratamiento farmacológico , Tumor de Wilms/patologíaRESUMEN
Scedosporium apiospermum (also known as Pseudallescheria boydii) is a ubiquitous filamentous fungus. This fungus is known as a cause of mycetoma, which may occur in a normal immune host following trauma and nonmycetoma-localized skin infections without grain production which are much rarer. However, in an immunocompromised host, S. apiospermum may cause a life-threatening infection. We describe a case of S. apiospermum infection of the left middle finger in an immunocompetent patient, which was diagnosed on cytology and later confirmed on culture.
Asunto(s)
Dermatomicosis/patología , Infecciones Fúngicas Invasoras/patología , Dermatomicosis/microbiología , Dedos/microbiología , Dedos/patología , Humanos , Infecciones Fúngicas Invasoras/microbiología , Masculino , Persona de Mediana Edad , Scedosporium/patogenicidad , Piel/microbiología , Piel/patologíaRESUMEN
BACKGROUND: Many studies have shown that invasive pulmonary aspergillosis, cryptococcosis, and mucormycosis can mimic radiographic and clinical features of primary lung cancer. However, more research surveying the incidence and outcomes of these fungal infections among patients with a history of lung cancer is needed. The aim of this study was to describe the occurrence and clinical outcomes of opportunistic invasive fungal infections that can mimic tumors in non-small-cell lung cancer patients. PATIENTS AND METHODS: Patients seen at Stanford University Medical Center from January 1, 2007, to May 1, 2020, with pulmonary aspergillosis, cryptococcosis, or mucormycosis after non-small-cell lung cancer (NSCLC) diagnosis were reviewed. The European Organization for Research and Treatment of Cancer National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria was used to classify patients with evidence of proven or probable invasive fungal infection within our cohort. RESULTS: A total of 12 patients with proven or probable invasive mold infection (including 8 cases of aspergillosis) and 1 patient with proven cryptococcosis were identified, without any cases of mucormycosis. Of this cohort, 6 patients (46%) showed radiographic findings that were found to be most consistent with lung cancer by radiologists. Eight cases (62%) were suspected of cancer recurrence or progression by the treatment team on the basis of additional considerations of medical history and clinical symptoms. Most patients had active NSCLC or had a history of recurrence without active NSCLC at the time of fungal discovery (11 patients; 85%). Most patients died without full recovery (7 patients; 54%). CONCLUSIONS: Invasive pulmonary aspergillosis and cryptococcosis can often be mistaken as cancer recurrence or progression in patients with a history of NSCLC because of mimicking radiographic and clinical characteristics.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/complicaciones , Infecciones Fúngicas Invasoras/complicaciones , Neoplasias Pulmonares/complicaciones , Infecciones Oportunistas/complicaciones , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Antineoplásicos/uso terapéutico , Aspergilosis/complicaciones , Aspergilosis/diagnóstico , Aspergilosis/patología , Aspergilosis/terapia , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Carcinoma de Pulmón de Células no Pequeñas/patología , Carcinoma de Pulmón de Células no Pequeñas/terapia , Criptococosis/complicaciones , Criptococosis/diagnóstico , Criptococosis/patología , Criptococosis/terapia , Diagnóstico Diferencial , Femenino , Humanos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/patología , Infecciones Fúngicas Invasoras/terapia , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/patología , Infecciones Oportunistas/terapia , Resultado del TratamientoRESUMEN
The genera Acremonium and Sarocladium comprise a high diversity of morphologically and genetically related fungi generally found in the environment, although a few species, mainly Sarocladium kiliense and Acremonium egyptiacum, can also be involved in many human infections. Clinical management of opportunistic infections caused by these fungi is very complex, since their correct identification is unreliable, and they generally show poor antifungal response. More than 300 clinical cases involving a broad range of Acremonium/Sarocladium infections have so far been published, and with this review we aim to compile and provide a detailed overview of the current knowledge on Acremonium/Sarocladium human infections in terms of presentation, diagnosis, treatments and prognoses. We also aim to summarise and discuss the data currently available on their antifungal susceptibility, emphasising the promising results obtained with voriconazole as well as their impact in terms of animal infections.
Asunto(s)
Hypocreales , Micosis , Infecciones Oportunistas , Acremonium/clasificación , Acremonium/efectos de los fármacos , Acremonium/aislamiento & purificación , Acremonium/patogenicidad , Animales , Antifúngicos/uso terapéutico , Artritis/tratamiento farmacológico , Artritis/microbiología , Sangre/microbiología , Infecciones del Sistema Nervioso Central/tratamiento farmacológico , Infecciones del Sistema Nervioso Central/microbiología , Dermatomicosis/tratamiento farmacológico , Farmacorresistencia Fúngica , Endocarditis/tratamiento farmacológico , Endocarditis/microbiología , Infecciones del Ojo/tratamiento farmacológico , Infecciones del Ojo/microbiología , Humanos , Hypocreales/clasificación , Hypocreales/efectos de los fármacos , Hypocreales/aislamiento & purificación , Hypocreales/patogenicidad , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/patología , Micetoma/tratamiento farmacológico , Micosis/tratamiento farmacológico , Micosis/patología , Micosis/veterinaria , Onicomicosis/tratamiento farmacológico , Onicomicosis/microbiología , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/patología , Infecciones Oportunistas/veterinaria , Osteomielitis/tratamiento farmacológico , Osteomielitis/microbiología , Peritonitis/tratamiento farmacológico , Peritonitis/microbiología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/microbiología , Voriconazol/uso terapéuticoRESUMEN
BACKGROUND: Antifungal prophylaxis during induction for acute myeloid leukemia (AML) varies according to local rates of invasive fungal infections (IFIs). We evaluated fluconazole prophylaxis and no antifungal prophylaxis, as a natural interrupted time-series study to assess survival and infection complications. PATIENTS AND METHODS: We identified patients with AML ≥ 18 years old undergoing induction chemotherapy during 2 time periods: period 1, fluconazole prophylaxis from August 1, 2013 to September 30, 2015, and period 2, no prophylaxis from October 1, 2015 to December 31, 2017. The primary outcome was incidence of proven or probable IFI. Secondary outcomes included types of IFIs and 60-day overall survival (OS). IFI was defined by the 2002 European Organization for Research and Treatment of Cancer/Mycoses Study Group Consensus criteria. RESULTS: One hundred forty-four patients received induction chemotherapy over the 2 time periods. In the prophylaxis versus no-prophylaxis groups, the rate of proven or probable IFIs was 4 (5%) of 87 versus 12 (21%) of 57 (P = .01). The total number of proven IFIs was 3 (3%) of 87 versus 4 (7%) of 57 (P = .44), whereas probable IFIs were 1 (1%) of 87 versus 8 (14%) of 57 (P < .01). No difference was observed in fungemia. Incidence of IFIs was too low to detect resistance patterns. OS at 60 days was improved in with fluconazole prophylaxis compared with no prophylaxis (hazard ratio, 0.329; 95% confidence interval, 0.12-0.89; P = .028). CONCLUSION: Observed rates of proven or probable IFI were lower in the fluconazole prophylaxis group versus the no-prophylaxis group. Sixty-day OS was higher with fluconazole prophylaxis. Further study is required to evaluate how fluconazole may impart the differences in survival seen in this analysis.
Asunto(s)
Antifúngicos/uso terapéutico , Infecciones Fúngicas Invasoras/etiología , Leucemia Mieloide Aguda/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Incidencia , Infecciones Fúngicas Invasoras/patología , Leucemia Mieloide Aguda/patología , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
PURPOSE: Despite antifungal prophylaxis, liver transplanted patients are endangered by invasive fungal infections (IFI). Routinely used microbiological procedures are hallmarked by significant weaknesses, which may lead to a delay in antifungal treatment. METHODS: Culture-based fungal findings, routinely used biomarkers of infection/inflammation (e.g., procalcitonin or C-reactive protein), as well as corresponding plasma concentrations of soluble Intercellular Adhesion Molecule (ICAM)-1 were analysed in 93 patients during a period of 28 days following liver transplantation (LTX). RESULTS: Plasmatic sICAM-1 was significantly elevated in patients affected by an IFI within the first 28 days in comparison to fungally colonised or unobtrusive LTX patients. sICAM-1 might therefore be helpful for the identification of IFI patients after LTX (e.g., Receiver Operating Characteristic (ROC)-Area Under the Curve (AUC): 0.714 at 14d after LTX). The diagnostic performance of sICAM-1 was further improved by its combined use with different other IFI biomarkers (e.g., midregional proadrenomedullin). CONCLUSION: The diagnostic deficiencies of routinely used microbiological procedures for IFI detection in patients after LTX may be reduced by plasmatic sICAM-1 measurements. Clinical Trial Notation. German Clinical Trials Register: DRKS00005480.
Asunto(s)
Biomarcadores/sangre , Molécula 1 de Adhesión Intercelular/genética , Infecciones Fúngicas Invasoras/sangre , Trasplante de Hígado/efectos adversos , Adulto , Antifúngicos/uso terapéutico , Proteína C-Reactiva/genética , Femenino , Humanos , Molécula 1 de Adhesión Intercelular/sangre , Infecciones Fúngicas Invasoras/complicaciones , Infecciones Fúngicas Invasoras/microbiología , Infecciones Fúngicas Invasoras/patología , Masculino , Persona de Mediana Edad , Factores de RiesgoAsunto(s)
Fusariosis/complicaciones , Fusarium/patogenicidad , Infecciones Fúngicas Invasoras/complicaciones , Infecciones Oportunistas/complicaciones , Antifúngicos/uso terapéutico , Fusariosis/diagnóstico , Fusariosis/patología , Fusariosis/terapia , Fusarium/aislamiento & purificación , Humanos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/patología , Infecciones Fúngicas Invasoras/terapia , Leucemia Bifenotípica Aguda/complicaciones , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/patología , Infecciones Oportunistas/terapia , Resultado del TratamientoRESUMEN
Gastric perforation is among one of the common indications for a laparotomy. It can occur as a result of an erosive ulcer, long term usage of NSAIDs and malignancy among other causes. Here we report a case of a 70-year-old man with an invasive fungal infection as a cause of his gastric perforation based on histopathological evidence. Although very rare it should be kept in mind as an etiological factor of upper GI perforation especially in old age patients. To the best of our knowledge no previous data on such an association has been reported in our country.
Asunto(s)
Infecciones Fúngicas Invasoras , Gastropatías , Anciano , Humanos , Infecciones Fúngicas Invasoras/complicaciones , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/patología , Masculino , Estómago/microbiología , Estómago/patología , Gastropatías/diagnóstico , Gastropatías/microbiología , Gastropatías/patologíaAsunto(s)
Infecciones Fúngicas Invasoras , Leucemia Mieloide Aguda/complicaciones , Micosis , Tomografía de Emisión de Positrones , Anciano , Anidulafungina/uso terapéutico , Antifúngicos/uso terapéutico , Combinación de Medicamentos , Humanos , Huésped Inmunocomprometido , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/patología , Riñón/diagnóstico por imagen , Riñón/microbiología , Riñón/patología , Hígado/diagnóstico por imagen , Hígado/microbiología , Hígado/patología , Masculino , Micosis/diagnóstico , Micosis/tratamiento farmacológico , Micosis/patología , Nitrilos/uso terapéutico , Piridinas/uso terapéutico , Bazo/diagnóstico por imagen , Bazo/microbiología , Bazo/patología , Resultado del Tratamiento , Triazoles/uso terapéuticoRESUMEN
Fungal infections cause substantial morbidity and mortality. However, the burden of deep fungal infections is not well described in Uganda. We aimed to estimate the burden and etiology of histologically diagnosed deep fungal infections in Uganda. We retrospectively reviewed histology reports at the Pathology Reference Laboratory, Department of Pathology, Makerere University, Kampala, Uganda from January 1950 to September 2019 to identify any reports that had a fungal infection as the diagnosis. Over the study period, 697 cases of deep fungal infections were identified with an average incidence of 0.73/100,000 persons per decade. There was a general decline in the number of cases detected. Median age of the cases was 28 years (IQR: 11-40) and majority (59%) were male. The age group of 0-10 years were the most affected. The foot was the most affected part of the body (26%). Deep mycoses identified include eumycetoma (32%), subcutaneous phycomycosis (26%), histoplasmosis (9.2%), chromoblastomycosis (4.6%), aspergillosis (3.3%), cryptococcosis (3.3%), blastomycosis (1.6%), subcutaneous mycosis (1.4%), dermatomycosis (1.3%), coccidioidomycosis (0.6%), mucormycosis (0.6%), and sporotrichosis (0.1%). Histoplasma was the commonest causative agent (9.2%) followed by Aspergillus (3.4%) and Cryptococcus (3.3%), while 81% of the fungal pathogens were not identified to genus/species level. Only 31% of the cases were diagnosed clinically as deep fungal infections. There is a substantial burden of deep fungal infections caused by multiple fungal pathogens in Uganda. There is need to build local capacity for mycology so as to improve on the index of clinical suspicion and diagnostic capabilities.
Asunto(s)
Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/patología , Adolescente , Adulto , Niño , Costo de Enfermedad , Femenino , Hongos/clasificación , Hongos/aislamiento & purificación , Hongos/patogenicidad , Humanos , Incidencia , Infecciones Fúngicas Invasoras/epidemiología , Infecciones Fúngicas Invasoras/microbiología , Laboratorios de Hospital/estadística & datos numéricos , Masculino , Estudios Retrospectivos , Uganda/epidemiología , Adulto JovenAsunto(s)
Dermatomicosis/patología , Infecciones Fúngicas Invasoras/patología , Otitis Externa/patología , Anciano , Dermatomicosis/microbiología , Pabellón Auricular/microbiología , Pabellón Auricular/patología , Femenino , Humanos , Infecciones Fúngicas Invasoras/microbiología , Ilustración Médica , Otitis Externa/microbiologíaRESUMEN
BACKGROUND: Patients with hematological malignancies and allogeneic hematopoietic stem-cell transplant recipients carry a high risk of rare (non-Aspergillus molds and non-Candida yeasts) invasive fungal infections (IFI). METHODS: We retrospectively evaluated and described the patient profile, clinical manifestations, isolated species, treatment and outcome of patients with hematological malignancies diagnosed with these rare IFIs during 15 years in a large single hemato-oncology center. RESULTS: Eighty-seven patients with hematological malignancies treated in our center had at least one positive culture or molecular identification of a rare fungus. Ninety-three isolates were considered the etiological agents of the infection. The most common underlying hematological malignancy was acute myeloid leukemia, 36 patients (41.4%). Eighty patients (91%) received chemotherapy less than 30 days prior to IFI diagnosis. The most frequent site of infection was the respiratory tract: 34 patients (39%) had pulmonary and 19 patients (22%) had a sinusal or nasopharyngeal infections. Disseminated infection, defined as positive blood cultures or parallel infection in multiple organ systems, was documented in 20 patients (23%). The most common fungal species were Fusarium (35%) and Zygomycetes (25%). Coinfection with more than one fungus was noted in 20 patients (23%). Forty-seven of 87 patients (54%) in this study died within 90 days of IFI diagnosis. CONCLUSIONS: Rare IFIs in patients with hematological malignancy become increasingly frequent. Early identification with traditional and molecular methods is important in management of these patients.
Asunto(s)
Neoplasias Hematológicas/complicaciones , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Infecciones Fúngicas Invasoras , Micosis , Adolescente , Adulto , Anciano , Niño , Preescolar , Coinfección , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Femenino , Hongos/clasificación , Hongos/aislamiento & purificación , Hongos/patogenicidad , Fusarium/clasificación , Fusarium/aislamiento & purificación , Fusarium/patogenicidad , Humanos , Inmunosupresores/efectos adversos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/patología , Leucemia Mieloide Aguda/complicaciones , Masculino , Persona de Mediana Edad , Micosis/diagnóstico , Micosis/patología , Estudios Retrospectivos , Centros de Atención Terciaria , Adulto Joven , CigomicosisRESUMEN
Invasive aspergillosis (IA) is the most common invasive fungal infection following a hematopoietic cell transplant, with emerging cryptic species exhibiting resistance to commonly used antifungals such as azoles. These species have been increasingly found after the introduction of anti-mold prophylaxis. We report a case of a 56-year-old female with primary myelofibrosis whose allogeneic hematopoietic cell transplant was complicated by disseminated fungal infection (skin, lung) due to Aspergillus calidoustus, a cryptic specie. Treatment of Aspergillus species remains challenging as these cryptic species are usually resistant to azoles including voriconazole which is the first line of treatment of IA. Infection was successfully treated with surgical excision and combination antifungal therapy based on in vitro susceptibility and synergy testing. Therapy included isavuconazole, a drug that has been shown to be non-inferior to voriconazole in the treatment of invasive mold infections.